Dear Users,

The journal ratings for SCImago Journal & Country Rank 2024 have been published.

https://www.scimagojr.com/

Sarkady Ferenc

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2013-2022

2022

Sadeghi, F., Sarkady, F., Zsóri, K. S., Szegedi, I., Orbán-Kálmándi, R. A., Székely, E. G., Molnárné Vasas, N., Berényi, E., Csiba, L., Bagoly, Z., Shemirani, A. H.: High Neutrophil-Lymphocyte Ratio and Low Lymphocyte-Monocyte Ratio Combination after Thrombolysis Is a Potential Predictor of Poor Functional Outcome of Acute Ischemic Stroke.
J. Pers. Med. 12 (8), 1-12, (article identifier: 1221), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous)

2021

Orbán-Kálmándi, R. A., Szegedi, I., Sarkady, F., Fekete, I., Fekete, K., Molnárné Vasas, N., Berényi, E., Csiba, L., Bagoly, Z.: A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis.
Sci. Rep. 11 (1), 1-14, 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

Orbán-Kálmándi, R. A., Árokszállási, T., Fekete, I., Fekete, K., Héja, M., Tóth, J., Sarkady, F., Csiba, L., Bagoly, Z.: A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients: the IRONHEART Study.
Front. Neurol. 12, 1-11, 2021.

doi DEA

Journal metrics:

Q2 Neurology

Q1 Neurology (clinical)

Szegedi, I., Orbán-Kálmándi, R. A., Nagy, A. C., Sarkady, F., Molnárné Vasas, N., Sik, M., Lánczi, L., Berényi, E., Oláh, L., Crișan, A., Csiba, L., Bagoly, Z.: Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.
PLoS One. 16 (7), 1-16, 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Multidisciplinary

Bagoly, Z., Baráth, B., Orbán-Kálmándi, R. A., Szegedi, I., Kissné Bogáti, R., Sarkady, F., Csiba, L., Katona, É.: Incorporation of [alfa]2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Biomolecules. 11 (3), 1-13, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Molecular Biology

Árokszállási, T., Héja, M., Bagoly, Z., Kovács, K. B., Orbán-Kálmándi, R. A., Sarkady, F., Tóth, J., Fekete, K., Fekete, I., Csiba, L.: Prognostic value of various hemostasis parameters and neurophysiological examinations in spontaneous intracerebral hemorrhage: the IRONHEART study protocol.
Front. Neurol. 12, 1-6, 2021.

doi DEA

Journal metrics:

Q2 Neurology

Q1 Neurology (clinical)

2020

Hajas, O., Bagoly, Z., Tóth, N. K., Urbancsek, R., Kiss, A., Kovács, K. B., Sarkady, F., Nagy, A. C., Oláh, A., Nagy, L. T., Clemens, M., Csiba, L., Csanádi, Z.: Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques.
Cardiol Res Pract. 2020, 1-8, 2020.

doi DEA

Journal metrics:

Q3 Cardiology and Cardiovascular Medicine

Ząbczyk, M., Natorska, J., Bagoly, Z., Sarkady, F., Baráth, B., Katona, É., Bryk, A. H., Zettl, K., Wisniewski, J. R., Undas, A.: Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.
J. Physiol. Pharmacol. 71 (4), 519-524, 2020.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

Q2 Physiology

Bagoly, Z., Hajas, O., Urbancsek, R., Kiss, A., Fiák, E., Sarkady, F., Tóth, N. K., Orbán-Kálmándi, R. A., Kovács, K. B., Nagy, L. T., Nagy, A. C., Kappelmayer, J., Csiba, L., Csanádi, Z.: Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation.
J Clin Med. 9 (9), 1-13, 2020.

doi DEA WoS Scopus

2019

10.

Szegedi, I., Nagy, A. C., Székely, E. G., Czuriga-Kovács, K. R., Sarkady, F., Lánczi, L., Berényi, E., Csiba, L., Bagoly, Z.: PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients.
Ann. Clin. Trans. Neurol. 6 (11), 2240-2250, 2019.

doi DEA WoS Scopus

Journal metrics:

D1 Neurology (clinical)

Q1 Neuroscience (miscellaneous)

11.

Szegedi, I., Árokszállási, T., Fekete, I., Fekete, K., Nagy, A., Sarkady, F., Székely, E. G., Czuriga-Kovács, K. R., Berényi, E., Bagoly, Z., Csiba, L.: The association of plasminogen activator inhibitor-1 (pai-1) 4g/5g polymorphism with the risk and prognosis of intracerebral hemorrhage.
Eur. Stroke J. 4 (Suppl.), 470, 2019.

DEA

12.

Orbán-Kálmándi, R. A., Szegedi, I., Fekete, I., Fekete, K., Sarkady, F., Varga, L., Csiba, L., Bagoly, Z.: The use of ex vivo clot lysis assay for predicting outcomes in acute ischemic stroke patients who underwent intravenous thrombolysis.
Eur. Stroke J. 4 (Suppl.), 742-743, 2019.

DEA

2018

13.

Tóth, N. K., Székely, E. G., Czuriga-Kovács, K. R., Sarkady, F., Nagy, O., Lánczi, L., Berényi, E., Fekete, K., Fekete, I., Csiba, L., Bagoly, Z.: Elevated factor VIII and von Willebrand factor levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis.
Front. Neurol. 8, 1-10, 2018.

doi DEA

Journal metrics:

Q2 Neurology

Q2 Neurology (clinical)

2017

14.

Tóth, N. K., Csanádi, Z., Hajas, O., Kiss, A., Nagy-Baló, E., Kovács, K. B., Sarkady, F., Muszbek, L., Bereczky, Z., Csiba, L., Bagoly, Z.: Intracardiac hemostasis and fibrinolysis parameters in patients with atrial fibrillation.
Biomed Res. Int. 2017, 1-10, 2017.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Immunology and Microbiology (miscellaneous)

Q1 Medicine (miscellaneous)

2016

15.

Bagoly, Z., Homoródi, N., Kovács, E. G., Sarkady, F., Csiba, L., Édes, I., Muszbek, L.: How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?.
Platelets. 27 (1), 59-65, 2016.

doi DEA

Journal metrics:

Q2 Hematology

Q2 Medicine (miscellaneous)

2013

16.

Bagoly, Z., Sarkady, F., Magyar, M. T., Kappelmayer, J., Pongrácz, E., Csiba, L., Muszbek, L.: Comparison of a New P2Y12 Receptor Specific Platelet Aggregation Test with Other Laboratory Methods in Stroke Patients on Clopidogrel Monotherapy.
PLoS One. 8 (7), e69417, 2013.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)